RGABX
Price
$69.54
Change
-$0.84 (-1.19%)
Updated
Jun 13 closing price
Net Assets
306.22B
WBGSX
Price
$8.62
Change
-$0.14 (-1.60%)
Updated
Jun 13 closing price
Net Assets
224.84M
Interact to see
Advertisement

RGABX vs WBGSX

Header iconRGABX vs WBGSX Comparison
Open Charts RGABX vs WBGSXBanner chart's image
American Funds Growth Fund of Amer R2
Price$69.54
Change-$0.84 (-1.19%)
VolumeN/A
Net Assets306.22B
William Blair Growth N
Price$8.62
Change-$0.14 (-1.60%)
VolumeN/A
Net Assets224.84M
RGABX vs WBGSX Comparison Chart
Loading...
View a ticker or compare two or three
VS
RGABX vs. WBGSX commentary
Jun 15, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RGABX is a Buy and WBGSX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RGABX has more cash in the bank: 306B vs. WBGSX (225M). RGABX (0.00) and WBGSX (0.00) have matching dividends . RGABX was incepted earlier than WBGSX: RGABX (23 years) vs WBGSX (79 years). RGABX (1.39) is less costly to investors than WBGSX (1.23). WBGSX is a more actively managed with annual turnover of: 49.00 vs. RGABX (25.00). RGABX has a lower initial minimum investment than WBGSX: RGABX (250) vs WBGSX (2500). RGABX annual gain was more profitable for investors over the last year : 6.71 vs. WBGSX (-20.55). RGABX return over 5 years is better than : 40.63 vs. WBGSX (-12.13).
RGABXWBGSXRGABX / WBGSX
Total Expense Ratio1.391.20116%
Annual Report Gross Expense Ratio1.391.23113%
Fund Existence23 years79 years-
Gain YTD4.697-1.934-243%
Front LoadN/AN/A-
Min. Initial Investment250250010%
Min. Initial Investment IRAN/AN/A-
Net Assets306B225M136,000%
Annual Yield % from dividends0.000.00-
Returns for 1 year6.71-20.55-33%
Returns for 3 years47.803.231,478%
Returns for 5 years40.63-12.13-335%
Returns for 10 years59.02-39.08-151%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
BBIO39.780.13
+0.33%
BridgeBio Pharma
AAPL196.45-2.75
-1.38%
Apple
SPHR38.22-0.99
-2.52%
Sphere Entertainment Co
RMR15.78-0.53
-3.25%
RMR Group (The)
VTGN2.21-0.11
-4.54%
VistaGen Therapeutics